The overall aim of SHE is to improve the health of children and young people in Europe, including reducing health inequalities, through a setting focus on schools. SHE supports its members to further develop and sustain school health promotion in each EU Member State by providing a European platform for school health promotion. SHE contributes to national and regional development and implementation of school health promotion, as well as the development of new knowledge and evidence. For the period 2018-2021 three specific objectives are formulated based on the mission and purpose of SHE: 1) By the end of 2021 the functioning of national and regional health promoting school networks and the implementation of health promoting schools has been supported by sharing good practices, expertise and skills and reinforcing the position of SHE national and regional coordinators; 2) By the end of 2021 the professional competence development of the SHE members and other stakeholders has been supported by the delivery of the SHE support programme; 3) By the end of 2021 the visibility and access to evidence based information on school health promotion has increased by the delivery of SHE publications and presentations. Methods to achieve these objectives are: organising annual meetings and capacity building workshops; maintaining SHE website, helpdesk, share information through newsletters and social media and encourage regional and cross-border cooperation. Developing online school twinning tool, teacher training material on health & wellbeing; the SHE online school manual; developing an e-learning tool, organising the SHE academy, support publications and consultancy visits. Making SHE leaflets, factsheets, an online glossary and representing SHE at international conferences; developing European standards and indicators for health promoting schools.


EuroHealthNet is a leading Partnership bringing together organisations, agencies and statutory bodies to contribute to our common mission of improving health and tackling health inequalities between and within European States.
Health inequalities are unfair and have a huge economic and social costs. Support from the 3rd Health Programme will enable EuroHealthNet to contribute: (1) to reducing health inequalities in Europe, by encouraging countries to act, through consolidated action on the social determinants of health, with a particular focus on children and young people; (2) to reducing the burden of chronic diseases and improving mental health and well-being; (3) to contribute to more innovative, sustainable and equitable health system, by strengthening the role of promotion and disease prevention; and (4) to achieving a high quality and effective European Partnership for improving health equity and well-being.

EuroHealthNet will realise these objectives through cross-cutting work in our three Platforms and through our core services:
POLICY: we monitor, analyse and influence policy at EU and national level and across sectors. We provide guidance to the Partnership about EU policies and vice versa.
PRACTICE: we build capacity and share knowledge among members and associates so that they can learn from and inspire one another, reinforce resources, shape initiatives and implement more ‘state of the art’ approaches in the relevant areas.
RESEARCH: we build the evidence base for effective policies and practices and share the latest evidence with researchers, policy makers and practitioners.
Our core services, which involve our highly effective communication activities, the coordination of Thematic Working Groups (TWIGs), membership development, administration and evaluation, reinforce our work. Our 2018-21 work programme, which focuses on one strategic objective per year, directly contributes to 3/4ths of the objectives of the 3rd Health Programme.


Thalassaemia, a previously fatal childhood genetic disease, can today be effectively prevented and appropriately treated, as a result of medical and scientific advances in the last three decades. However, thalassaemia’s prioritisation on national health agendas and the development of national plans for its effective control in the EU has been hampered by the many challenges involved, mainly related to its rarity and migration.

THALassaemia In Action (THALIA) focuses on Europe, targeting patients with thalassaemia and other haemoglobinopathies, healthcare professionals and policymakers and aims to attain four general objectives, based on TIF’s main pillars of activities:

1. Continue and strengthen the education of patients/parents and healthcare professionals, as well as the patients’ capacity, competency and networking within and across countries and regions of Europe. This is to be achieved via the development of e-learning tools and the launching of capacity building courses and training seminars.

2. Raise awareness on thalassaemia and the importance of optimal care amongst the public at large, as well as among THALIA target groups at national and European level. This will be attained using an array of online tools, activities and publications.

3. Prioritise haemoglobin disorders and their control (prevention and management) at European level. This will be accomplished by establishing and training national patients’ associations in EU priority countries, creating an EU Electronic Health Record and entering into policy dialogue with policymakers at national and European level.

4. Support research programmes and studies focused on the clinical management of Thalassaemia. This is to be achieved via the publication of guidelines on the clinical management of Thalassaemia, participating in scientific conferences and providing medical specialists in priority countries with fellowships.

Knowledge is our power.
